MDxHealth SA Return on Tangible Equity 2018-2023 | MDXH
MDxHealth SA Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2023-03-31 | $-0.02B | $-0.04B | 88.89% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.000B | $0.070B |
MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $37.024B | 20.33 |
Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
Axonics (AXNX) | United States | $3.435B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
10x Genomics (TXG) | United States | $3.022B | 0.00 |
Azenta (AZTA) | United States | $3.015B | 163.85 |
Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
Enovis (ENOV) | United States | $2.779B | 20.60 |
Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
Privia Health (PRVA) | United States | $2.238B | 99.26 |
Schrodinger (SDGR) | United States | $1.679B | 0.00 |
Omnicell (OMCL) | United States | $1.376B | 47.56 |
Phreesia (PHR) | United States | $1.237B | 0.00 |
Standard BioTools (LAB) | United States | $0.650B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
Talkspace (TALK) | United States | $0.451B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.431B | 0.00 |
Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
Pulmonx (LUNG) | United States | $0.342B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
Outset Medical (OM) | United States | $0.214B | 0.00 |
Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
American Well (AMWL) | United States | $0.150B | 0.00 |
Augmedix (AUGX) | United States | $0.128B | 0.00 |
TruBridge (TBRG) | United States | $0.121B | 5.17 |
MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
111 (YI) | China | $0.094B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
HeartBeam (BEAT) | United States | $0.055B | 0.00 |
Zepp Health (ZEPP) | China | $0.051B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
Movano (MOVE) | United States | $0.039B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
Cue Health (HLTH) | United States | $0.021B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Syra Health (SYRA) | United States | $0.012B | 0.00 |
Biotricity (BTCY) | United States | $0.011B | 0.00 |
ETAO (ETAO) | United States | $0.010B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |